UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.292-299

2020

Volltextzugriff (PDF)

Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

BMC rheumatology, 2020-06, Vol.4 (1), p.42-16, Article 42

2020

Volltextzugriff (PDF)

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.654-660

2017

Volltextzugriff (PDF)

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Rheumatology (Oxford, England), 2011-01, Vol.50 (1), p.124-131

2011

Volltextzugriff (PDF)

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.522-528

2010

Volltextzugriff (PDF)

Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus

Clinical rheumatology, 2007-01, Vol.26 (1), p.24-29

2007

Volltextzugriff (PDF)

Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-10, Vol.73 (10), p.1800-1809

2021

Volltextzugriff (PDF)

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2162-2169

2019

Volltextzugriff (PDF)

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2009-02, Vol.68 (2), p.209-215

2009

Volltextzugriff (PDF)

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

Arthritis care & research (2010), 2010-06, Vol.62 (6), p.755-763

2010

Volltextzugriff (PDF)

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1086-1091

2010

Volltextzugriff (PDF)

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

Rheumatology (Oxford, England), 2016-11, Vol.55 (11), p.2033-2039

2016

Volltextzugriff (PDF)

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.869-874

2012

Volltextzugriff (PDF)

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology (Oxford, England), 2020-03, Vol.59 (3), p.559-567

2020

Volltextzugriff (PDF)

Long-term persistence with rituximab in patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2018-06, Vol.57 (6), p.1089-1096

2018

Volltextzugriff (PDF)

Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

PloS one, 2019-05, Vol.14 (5), p.e0215999-e0215999

2019

Volltextzugriff (PDF)

Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification

American journal of epidemiology, 2009-04, Vol.169 (7), p.909-917

2009

Volltextzugriff (PDF)

Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK

Annals of the rheumatic diseases, 2013-03, Vol.72 (3), p.461-462

2013

Volltextzugriff (PDF)

The Comparative Responsiveness of the EQ-5D and SF-6D to Change in Patients with Inflammatory Arthritis

Quality of life research, 2009-11, Vol.18 (9), p.1195-1205, Article 1195

2009

Volltextzugriff (PDF)

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

Rheumatology (Oxford, England), 2009-10, Vol.48 (10), p.1323-1327

2009

Volltextzugriff (PDF)

Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East

International journal of rheumatic diseases, 2015-03, Vol.18 (3), p.268-275

2015

Volltextzugriff (PDF)

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

Rheumatic & musculoskeletal diseases open, 2017-01, Vol.3 (1), p.e000314-e000314

2017

Volltextzugriff (PDF)

Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in A frica and the M iddle E ast

International journal of rheumatic diseases, 2015-03, Vol.18 (3), p.268-275

2015

Volltextzugriff (PDF)

Test your rheumatology

BMJ (Online), 2009-01, p.a2544

2009

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Rheumatology
(26)
Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Humans
(22)
Female
(19)
Male
(19)
Rheumatoid Arthritis
(19)
Arthritis, Rheumatoid - Drug Therapy
(17)
Middle Aged
(17)
Aged
(14)
Antirheumatic Agents - Therapeutic Use
(12)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(12)
Antirheumatic Agents - Adverse Effects
(11)
Registries
(10)
Adult
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Arthritis, Rheumatoid - Epidemiology
(8)
Diseases Of The Osteoarticular System
(8)
Epidemiology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)

Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus

Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Long-term persistence with rituximab in patients with rheumatoid arthritis

Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification

Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK

The Comparative Responsiveness of the EQ-5D and SF-6D to Change in Patients with Inflammatory Arthritis

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East

Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA

Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in A frica and the M iddle E ast

Test your rheumatology

Suchergebnisse filtern